ERYTECH Pharma S.A. (ERYP) Balance Sheet Annual

ERYTECH Pharma S.A.

ERYP (NASDAQ)

(%)

Financials
ERYTECH Pharma S.A. Balance Sheet Statement Annual

Annual Quarterly

* (except for per share items) of EUR

Period Ending:	2022 12-31	2021 12-31	2020 12-31	2019 12-31	2018 12-31	2017 12-31	2016 12-31	2015 12-31	2014 12-31	2013 12-31	2012 12-31
Report Filing:	2022-12-31	2022-04-27	2021-03-08	2020-03-18	2019-03-29	2018-04-24	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31
Total Current Assets	42.63	40.05	49.63	81.58	149.9	191.6	42.53	51.93	39.53	17.04	9.14
Cash and Short Term Investments	38.83	34.19	44.45	73.19	134.4	185.5	37.65	45.63	36.99	15.11	7.88
Cash & Equivalents	38.79	33.7	44.45	73.17	134.4	185.5	37.65	45.63	36.99	15.11	7.88
Short Term Investments	0.043	0.486	0.008	0.013	0	0	0	0	0	0	0
Receivables	2.53	4.23	4.33	-2.23	9.68	0	4.4	5.91	2.12	1.69	0.999
Inventory	1.27	0	0	0.358	1.4	0.176	0.145	0.166	0.198	0.138	0.116
Other Current Assets	0.001	1.63	0.844	10.27	4.46	5.87	0.34	0.219	0.217	0.101	0.149
Total Assets	45.81	66.77	80.4	118.5	167.8	195.3	44.97	53.01	40.61	17.95	10.14
Total Non-Current Assets	3.18	26.72	30.77	36.96	17.93	3.69	2.43	1.08	1.08	0.91	1.01
Property, Plant and Equipment	2.98	25.83	29.09	35.64	15.27	3.41	2.24	0.917	0.967	0.793	0.731
Goodwill and Intangible Assets	0.005	0.015	0.589	0.603	1.61	0.054	0.057	0.062	0.031	0.014	0.03
Goodwill	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0.005	0.015	0.589	0.603	1.61	0.054	0.057	0.062	0.031	0.014	0.03
Long Term Investments	0	0	0.017	0.017	0.091	0.066	0	0	0	0.083	0
Deferred Tax Assets	0	0	0	0.701	0	0	0	0	0	0	0.125
Other Long Term Assets	0.196	0.876	1.07	0.003	0.955	0.167	0.133	0.097	0.082	0.02	0.12
Total Current Liabilities	11.68	20	29.35	19.88	20.65	11.61	6.35	5.62	4.26	3.51	7.48
Accounts Payable	1.56	2.48	4.71	5.07	16.66	8.08	4.83	3.67	2.08	1.42	1.27
Notes Payable/Short Term Debt	3.34	1.98	3.87	1.52	0.777	0.825	0.05	0.557	0.334	0.281	4.63
Tax Payables	0	3.72	4.15	3.63	3.15	2.71	1.47	1.24	0.971	0.816	0.361
Deferred Revenue	0.051	0.093	0.148	0.061	0.016	2.71	0	1.24	0.368	0.649	0.943
Other Current Liabilities	6.72	11.73	16.47	9.59	0.052	-2.71	0	-1.09	0.501	0.347	0.271
Total Liabilities	22.32	43.92	53.86	32.99	22.24	13.84	9.33	5.87	4.78	4.36	14.17
Total Non-Current Liabilities	10.65	23.92	24.52	13.11	1.59	2.23	2.98	0.251	0.525	0.848	6.69
Total Long Term Debt	10.23	23.39	23.58	12.6	1.24	2.02	2.82	0.151	0.436	0.731	6.4
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0.003	0.003	0	0	0	0.125
Deferred Revenue Non-Current	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	0	0
Other Long Term Liabilities	0.42	0.524	0.94	0.507	0.346	0.212	0.163	0.1	0.089	0.117	0.171
Total Equity	23.49	22.84	26.54	85.56	145.6	0	0	0	0	0	0
Non-Controlling Interest	0	0	0	0	0	0	0	0	0	0	0
Total Stockholders' Equity	23.49	22.84	26.54	85.56	145.6	181.4	35.64	47.13	35.82	13.59	-4.03
Retained Earnings	-0.228	-53.8	-73.3	-62.66	-38.22	-33.53	-21.91	-15.01	-8.86	-8.14	-2.17
Accumulated Other Earnings	-28.36	-24.08	-22.87	-135.3	-99.71	-68.59	-48.41	-34.58	-28.43	-21.56	-19.94
Common Stock	3.1	3.1	2.01	1.79	1.79	1.79	0.873	0.792	0.688	0.551	0.315
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0
Additional Paid in Capital	48.98	97.62	120.7	281.7	281.7	281.7	105.1	95.93	72.43	42.74	17.77
Total Liabilities & Total Equity	45.81	66.77	80.4	118.5	167.8	195.3	44.97	53	40.61	17.95	10.14
Total Liabilities & Shareholders' Equity	45.81	66.77	80.4	118.5	167.8	195.3	44.97	53.01	40.61	17.95	10.14
Total Investments	0.043	0.486	0.025	0.03	0.091	0.066	0	0	0	0.083	0
Total Debt	13.57	25.38	27.45	14.12	2.02	2.85	2.87	0.708	0.77	1.01	11.03
Net Debt	-25.22	-8.32	-17	-59.05	-132.4	-182.7	-34.78	-44.93	-36.22	-14.1	3.15

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

ERYTECH Pharma S.A. Balance Sheet Statement Annual